Cancer BiologybioRxiv
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma
C. S. Koivisto, M. Parrish, S. B. Bonala…·G. Leone
This study evaluates enzalutamide's efficacy and resistance development in a mouse model of type-I endometrial carcinoma, finding it reduces tumor burden initially but promotes resistance with prolonged use.
DOI 10.1016/j.neo.2020.07.003